AU2001288436A1 - The identification and development of specific monoclonal antibodies to squamous cell carcinoma - Google Patents

The identification and development of specific monoclonal antibodies to squamous cell carcinoma

Info

Publication number
AU2001288436A1
AU2001288436A1 AU2001288436A AU8843601A AU2001288436A1 AU 2001288436 A1 AU2001288436 A1 AU 2001288436A1 AU 2001288436 A AU2001288436 A AU 2001288436A AU 8843601 A AU8843601 A AU 8843601A AU 2001288436 A1 AU2001288436 A1 AU 2001288436A1
Authority
AU
Australia
Prior art keywords
antibody
carcinoma
antigen
monoclonal antibody
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288436A
Other languages
English (en)
Inventor
Myron Arlen
Kwong Y. Tsang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Bioimmune Systems Inc
Original Assignee
INTERNAT BIOIMMUNE SYSTEMS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INTERNAT BIOIMMUNE SYSTEMS Inc filed Critical INTERNAT BIOIMMUNE SYSTEMS Inc
Publication of AU2001288436A1 publication Critical patent/AU2001288436A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001288436A 2000-09-01 2001-08-28 The identification and development of specific monoclonal antibodies to squamous cell carcinoma Abandoned AU2001288436A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22978500P 2000-09-01 2000-09-01
US60229785 2000-09-01
US23089000P 2000-09-05 2000-09-05
US60230890 2000-09-05
PCT/US2001/026734 WO2002020617A1 (en) 2000-09-01 2001-08-28 The identification and development of specific monoclonal antibodies to squamous cell carcinoma

Publications (1)

Publication Number Publication Date
AU2001288436A1 true AU2001288436A1 (en) 2002-03-22

Family

ID=26923607

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288436A Abandoned AU2001288436A1 (en) 2000-09-01 2001-08-28 The identification and development of specific monoclonal antibodies to squamous cell carcinoma

Country Status (6)

Country Link
US (1) US7491801B2 (ja)
EP (1) EP1320551A4 (ja)
JP (1) JP2004529849A (ja)
AU (1) AU2001288436A1 (ja)
CA (1) CA2421070A1 (ja)
WO (1) WO2002020617A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60200248T2 (de) 2002-08-01 2005-01-27 Mtm Laboratories Ag Verfahren für Lösung-basierte Diagnose
US20130189268A1 (en) 2010-06-22 2013-07-25 Precision Biologics, Inc. Colon and pancreas cancer specific antigens and antibodies
JP5221825B1 (ja) 2012-10-09 2013-06-26 コニカミノルタホールディングス株式会社 肺扁平上皮癌の検出方法
CN113049344B (zh) * 2021-04-20 2022-02-01 深圳天烁生物科技有限公司 细胞染色的质控品制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4713352A (en) 1981-08-31 1987-12-15 Sloan-Kettering Institute For Cancer Reseach Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
JPS60190722A (ja) * 1984-03-12 1985-09-28 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺癌単クロ−ン性抗体
JPS6115897A (ja) * 1984-06-29 1986-01-23 Suntory Ltd ヒト肝癌細胞を特異的に認識するモノクロ−ナル抗体
ZA858371B (en) * 1984-11-02 1987-03-25 Oncogen Monoclonal antibodies for human non-small cell lung carcinomas
DK276185D0 (da) 1984-11-09 1985-06-19 Novo Industri As Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse
DK532984D0 (da) * 1984-11-09 1984-11-09 Novo Industri As Monoklonale antistoffer, der genkender specifikke glycoproteiner producerede af humant planocellulaert lungecarcinom celler, fremgangsmaade til fremstilling af saadanne antistoffer, samt deres diagnostiske anvendelse
US4962187A (en) * 1984-11-28 1990-10-09 Cota Biotech Common antigen for colorectal and mucinous ovarian tumors and process for isolating the same
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US4712352A (en) * 1985-12-04 1987-12-15 Low R Glenn Modular construction system
US4916055A (en) * 1985-12-13 1990-04-10 Baylor College Of Medicine Detection of human cancer with a monoclonal antibody specific for antigen gp650
JPS6319561A (ja) * 1986-07-11 1988-01-27 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺癌単クロ−ン性抗体
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5212085A (en) * 1987-12-09 1993-05-18 The General Hospital Corporation Sf-25 colon adenocarcinoma antigen, and antibodies with recognize this antigen
US5688657A (en) * 1988-03-31 1997-11-18 International Bio-Immune Systems, Inc. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2110799A1 (en) 1991-06-14 1992-12-23 Arnold H. Horwitz Microbially-produced antibody fragments and their conjugates
JPH05317082A (ja) 1991-08-06 1993-12-03 Toray Ind Inc モノクローナル抗体およびその用途
AU7333794A (en) 1993-08-02 1995-02-28 Houston Biotechnology Incorporated Single-chain immunotoxin compositions and methods for preventing secondary cataracts
US5665848A (en) * 1996-05-20 1997-09-09 Dow Corning Corporation Crosslinkers for silazane polymers
US6541212B2 (en) 1997-03-10 2003-04-01 The Regents Of The University Of California Methods for detecting prostate stem cell antigen protein
EP1411962B1 (en) 2001-03-15 2011-01-19 Neogenix Oncology, Inc. Monoclonal antibody therapy for pancreas cancer

Also Published As

Publication number Publication date
CA2421070A1 (en) 2002-03-14
US20040136997A1 (en) 2004-07-15
WO2002020617A1 (en) 2002-03-14
EP1320551A1 (en) 2003-06-25
EP1320551A4 (en) 2006-12-20
US7491801B2 (en) 2009-02-17
JP2004529849A (ja) 2004-09-30

Similar Documents

Publication Publication Date Title
US7498129B2 (en) Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
US8728741B2 (en) Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
EP0394277B1 (en) Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
US7420039B2 (en) Individualized anti-cancer antibodies
US7247476B2 (en) Individualized anti-cancer antibodies
US5688657A (en) Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
RU2266298C2 (ru) Антитела к антигену эпителиальных опухолей желудочно-кишечного тракта человека, родственному альфа 6 бета 4 интегрину
US5879898A (en) Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors
WO2003047623A1 (en) Treatment of prostate cancer by inhibitors of ncam2
JPH05500600A (ja) スフィンゴ糖脂質に対する免疫応答を誘導する抗イディオタイプ抗体及びその使用
WO1994012631A1 (en) Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors
AU594305B2 (en) Monoclonal antibodies, a process for their preparation and their use
US7491801B2 (en) Identification and development of specific monoclonal antibodies to squamous cell carcinoma
US6270978B1 (en) Immunomethods for isolating and indentifying human influx peptide transporter
USRE39760E1 (en) Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
JPH05317088A (ja) 腫瘍関連抗原に対するモノクローナル抗体、その製造方法およびその使用
US6001359A (en) Diagnosis of colon carcinoma using monoclonal antibodies to human influx peptide transporter
US7303914B2 (en) Monoclonal antibody against human hepatoma and use thereof
EP1206702A1 (en) Melanoma associated antigen (hmw-maa) defined by a monoclonal antibody
US9539348B2 (en) Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted